Purpose: To assess the outcome of transurethral plasmakinetic vaporization (PKVP) in
the management of benign prostatic hyperplasia (BPH).
Patients and methods: From August 2010 to May 2012, 60 patients with obstructive
LUTS due to BPH were included in the study. All patients were evaluated by International Prostate Symptom Score (IPSS), general examination, digital rectal examination, PSA, routine laboratory examinations, pelvi-abdominal ultrasound, trans-rectal
ultrasound, and uroflowmetry. Patients with Qmax of 8 and
a prostate volume of >40 mL underwent transurethral PKVP.
Results: Mean age of the patients was 66.8±4.5 years. The mean times of the operation,
post-operative bladder irrigation, and post-operative catheterization were 63.8±13.9
minutes, 15.2±5.7 hours, and 23.9±5.2 hours, respectively. At 3 months of follow-up,
there were signifcant reductions in the mean IPSS from 23.4±3.5 to 9.2±3.7 (P=0.4),
mean PSA from 3.03±2.2 ng/mL to 1.2±1.04 ng/mL (P value=0.02), mean post voiding
residual urine from 149.8±59.5 mL to 46.9±24.1 mL (P value |
